CWGCX
Price
$74.44
Change
-$0.08 (-0.11%)
Updated
Oct 17 closing price
Net Assets
140.97B
MWEMX
Price
$49.86
Change
+$0.30 (+0.61%)
Updated
Oct 17 closing price
Net Assets
2.12B
Interact to see
Advertisement

CWGCX vs MWEMX

Header iconCWGCX vs MWEMX Comparison
Open Charts CWGCX vs MWEMXBanner chart's image
American Funds Capital World Gr&Inc C
Price$74.44
Change-$0.08 (-0.11%)
VolumeN/A
Net Assets140.97B
MFS Global Equity R6
Price$49.86
Change+$0.30 (+0.61%)
VolumeN/A
Net Assets2.12B
CWGCX vs MWEMX Comparison Chart in %
View a ticker or compare two or three
VS
CWGCX vs. MWEMX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CWGCX is a Hold and MWEMX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CWGCX has more cash in the bank: 141B vs. MWEMX (2.12B). MWEMX pays higher dividends than CWGCX: MWEMX (1.00) vs CWGCX (0.77). CWGCX was incepted earlier than MWEMX: CWGCX (25 years) vs MWEMX (13 years). CWGCX (1.49) is less costly to investors than MWEMX (0.84). CWGCX is a more actively managed with annual turnover of: 27.00 vs. MWEMX (18.00). MWEMX has a lower initial minimum investment than CWGCX: MWEMX (0) vs CWGCX (250). CWGCX annual gain was more profitable for investors over the last year : 10.05 vs. MWEMX (-6.64). CWGCX return over 5 years is better than : 46.65 vs. MWEMX (2.74).
CWGCXMWEMXCWGCX / MWEMX
Total Expense Ratio1.490.81184%
Annual Report Gross Expense Ratio1.490.84177%
Fund Existence25 years13 years-
Gain YTD19.42610.354188%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets141B2.12B6,667%
Annual Yield % from dividends0.771.0076%
Returns for 1 year10.05-6.64-151%
Returns for 3 years63.7310.56603%
Returns for 5 years46.652.741,702%
Returns for 10 years72.3846.48156%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IJPTX12.35N/A
N/A
VY® JPMorgan Emerging Markets Equity S2
FGTAX29.54N/A
N/A
Fidelity Advisor Mega Cap Stock A
VCIGX13.25N/A
N/A
VALIC Company I Dividend Value
ETAHX41.66N/A
N/A
Eventide Healthcare & Life Sciences A
MSBVX11.48N/A
N/A
Morgan Stanley American Resilience I